Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-037879
Filing Date
2025-03-12
Accepted
2025-03-12 16:00:02
Documents
2
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1526
2 POWER OF ATTORNEY cue-ex24_1.htm EX-24.1 9168
  Complete submission text file 0000950170-25-037879.txt   12176
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Sarraf Pasha (Reporting) CIK: 0002059447 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 25731616